Anong, Johaina S.

HRN: 22-71-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2023
CEFUROXIME 750MG (VIAL)
09/23/2023
09/29/2023
IVT
190mg
Q8
UTI, Gastritis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractPneumoniaIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: